The food and agriculture biotechnology (FAB) sector is poised to respond to some of society's most pressing challenges, including food security, climate change, population growth, and resource limitation. However, to realize this promise, substantial barriers to innovation must be overcome. Here, we draw upon industry experience and innovation management literature to analyze FAB innovation challenges, as well relevant frameworks for their resolution. In doing so, we identify two major FAB innovation challenges: specialized adoption uncertainty, and complex product-market fit across convergent value chains. We propose that these innovation challenges may be overcome by 1) prioritizing the establishment of organizational and social technology legitimacy, and 2) leveraging technology-market matching methods and open innovation practices.
Food and Agricultural Biotechnology (FAB) encompasses technology innovation designed to improve plants, animals, and microorganisms, as well as their cultivation, processing and use, so as to increase their economic, social, and health-related value. As such, the sector is comprised of a broad collection of innovation areas encompassing technologies that respond to changing consumer preferences in food production and consumption, opportunities in nutritional supplementation and preventative healthcare for humans and animals, issues of food security and environmental sustainability, the transition towards a 'biobased' economy and green chemistry alternatives to synthetics, and enabling novel material use such as bio-plastics and/or specialty ingredients ( Table 1) .
Although still emerging as a standalone innovation area, the FAB sector has seen immense growth over the past five years, and has attracted significant investment activity from angel investors, private equity, incubators and accelerators, as well as venture capital (VC) firms (both broad biotechnology funds and FAB-specific corporate VCs). In 2016 alone, there were a reported 580 FAB sector financing deals globally-worth approximately $3.2 billion USDmade with over 650 unique investors, including 14 dedicated VC FAB funds worth nearly $850 million USD 1 . Moreover, since 2014 over $10 billion USD has been invested into the FAB sector, compared with only $2.3 billion USD invested in total between 2010 and 2013 1 . While these figures highlight the substantial growth of the FAB sector, the industry as a whole is still in its infancy. For example, the broader biotechnology/biopharmaceutical (healthcare) sector in the US attracted over $11 billion USD investment in 2016 alone, out of the total $58.6 billion USD invested in the US that year and the approximately $100 USD invested globally 2 . Importantly, 57% of 2016 FAB sector investments were at the 1 AgFunder-https://agfunder.com/research/agtech-investing-report-2016 2 https://www.pwc.com/us/en/moneytree-report/assets/PwC & CB Insights MoneyTree Report - Seed stage 1 , which further highlights the nascent nature of the FAB sector, but also signals its substantial promise for innovation at the intersection of existing industries.
Undoubtedly, one of the driving forces for investment and growth in the FAB sector is the need for, and promise of, technological solutions to important food and agricultural issues. Food quality and security are fundamental to the health and well-being of societies worldwide, yet today unprecedented population growth, resource limitation, and climate change are beginning to challenge our ability to feed ourselves in never-before-seen ways Boehlje, Roucan-Kane, & Bröring, 2011; . The successful development and deployment of innovative technologies by focused, agile, and opportunistic FAB ventures can help overcome these challenges. However, in order to be successful in technology commercialization, FAB ventures must be cognizant of the barriers to innovation they may face and, more importantly, develop proactive strategies to cope with the aforementioned challenges. Indeed, the evolution of novel technologies, such as synthetic biology, robotics, and applied data science, as well as the emergence of the bio-economy, highlights the substantial need for an innovation management lens to be applied to the food and agricultural biotechnology sector.
In response, we draw upon technology and innovation management literature to analyze the FAB sector, thereby positioning it within the broader context of (Bröring, Leker, & Ruhmer, 2006a; Garcia & Calantone, 2002; O'Connor, 1998) .
Accordingly, technology innovators that comprise the latter category-often referred to as Science Based Ventures (SBVs) and defined as those who attempt to "not only use existing science but also to advance scientific knowledge and capture the value of the knowledge it creates" (Pisano, 2006 )-face significant barriers to successful technology development and deployment. These challenges have been broadly documented in the past, particularly in the context of advanced materials and nanotechnology ventures (Maine & Seegopaul, 2016) , and may include the following: highly visible yet unfamiliar to the public) (Hall, Bachor, & Matos, 2014; Maine & Garnsey, 2006; Maine & Seegopaul, 2016; Pisano, 2010) . Of note, these challenges stand in contrast to those facing other non-SBV technology-driven industries such as the information and communication technology (ICT) sector, which is characterized by low technology and market uncertainty, relatively low capital requirements, and short timeframes for commercialization (Cusumano, MacCormack, & Kemerer, 2009; MacCormack & Verganti, 2003) (Figure 1 ).
Notwithstanding ICT-type food and agriculture technologies, FAB ventures are more closely aligned to SBVs than other technology innovation sectors ( Figure   1 ). Indeed, many of the most promising FAB innovation categories, namely agricultural biotechnology, bioenergy and biomaterials, and innovative food, all face high technology uncertainty and must perform fundamental interdisciplinary research in diverse areas such as microbiology, genetics, human and animal nutrition, immunology, polymer and enzyme chemistry, bioengineering, synthetic biology, etc. As such, it is clear that the FAB sector must address the same broad set of barriers to innovation that affect other SBVs.
However, given that the sector seeks to bring radical innovation to otherwise low technology intensive industries with relatively low R&D spending and a culture of incremental, process-driven innovation (Trott & Simms, 2017) , it is clear that the FAB ventures must also overcome a set of sector-specific innovation challenges.
Positioning of the FAB Sector-Sector-specific innovation challenges
In addition to the broad innovation challenges facing SBVs, FAB ventures face a number of sector-specific barriers to innovation that arise from the application of biotechnology into a complex food and agriculture sector with substantial specialized technology and market adoption drivers, most notably vested consumer interest in an otherwise business-to-business sector ( Figure 1 and Table 2 ). Of note, while these challenges are not necessarily exclusive to the FAB sector, they are likely to be particularly relevant to radically innovative FAB ventures seeking to make major changes to the technological status quo of the food and agriculture industries.
In the next section, we examine two specific, yet strongly interconnected, FABsector challenges-specialized adoption uncertainty, and product-market fit across industry convergence-affected value chains-within the context of relevant innovation management frameworks. Indeed, we find that the FAB sector is subject to several convergence processes at the technology (e.g. genomics, biotechnology) and market (e.g. hybrid products such as preventative foods or personalized nutrition) levels. This both creates and reinforces specialized adoption uncertainty at the technological, commercial, organizational, and societal levels, which perpetuates the already complex challenge of finding the right product-market combination in hybrid convergent value chains and industries. secrets and proprietary knowledge of process and formulation innovation (Alfranca, Rama, & Tunzelmann, 2002; Arundel, 2001; Leiponen & Byma, 2009 ), may no longer be suitable for value creation and capture. Likewise, the ongoing debate between the scientific community and the consuming public (Leshner, 2015) over foods derived from genetically modified organisms (GMOs) highlights the power of societal uncertainty, and especially issues of risk perception, emotionality, tradition, and public opinion, on the adoption of FAB derived products.
How then do FAB ventures successfully develop and deploy innovations in a highly uncertain ecosystem where organizational and societal pressures have significant consequences on technology adoption? One approach may be to prioritize a structured and holistic analysis of technology, commercial, organizational and societal (TCOS) uncertainties, so as to facilitate the establishment of overall technology 'legitimacy' in two key areas-cognitive and socio-political (Hall et al., 2014) (Table 3) .
Within such a framework, cognitive legitimacy is defined as the "knowledge about the new activity and what is needed to succeed in an industry" (Hall et al., 2014) . On the other hand, socio-political legitimacy is defined as the "the value placed on an activity by cultural norms and political influences" (Hall et al., 2014) , and is concerned with overcoming both organizational and societal uncertainty.
Organizational uncertainty relates to the strength of an organization's appropriability regime with respect to a given technology. That is, how well is an organization able to create and capture value from the technological innovation that it creates (Teece, 1986 (Hall et al., 2014) . Thirdly, strong patent regimes requiring control by a select group of stakeholders may be prohibitive to collaborative R&D and open innovation practices (Laursen & Salter, 2014) , which are thought to be crucial for innovation in the FAB sector (Pellegrini, Lazzarotti, & Manzini, 2014; Saguy & Sirotinskaya, 2014; Sarkar & Costa, 2008) . Lastly, even though strong, patentenabled appropriability regimes are more transparent than trade secret-based regimes, consumers may still take exception to the level of authority and restriction exerted by patent holders seeking to enforce their patents-indeed, such a response has been seen previously towards multiple seed and crop technologies owned by multinational agribusinesses (Hall et al., 2014) .
With respect to societal uncertainty, public concerns surrounding GMOs and BEFs create an extremely high degree of specialized adoption uncertainty for ventures. This is perpetuated by the fact that many FAB ventures create technologies with high consumer visibility and impact (i.e. affecting food production, manufacturing, and nutrition), despite the fact that the sector as a whole occupies an upstream position in the value chain and thus is business-tobusiness oriented (i.e. process innovation for agriculture, novel ingredients, etc.).
Moreover, this upstream positioning in the value chain presents challenges for FAB ventures trying to communicate with end-customers, gather social and market intelligence, and interface with downstream users of their technology, especially if co-innovation and/or education is needed to drive adoption (Maine & Seegopaul, 2016 agricultural data science or food processing technologies-consumer perceptions of "unnatural" foods, so called "food neophobia" (Schnettler et al., 2013) , may create significant barriers to adoption.
Although a decade ago the negative public perceptions of GMOs and other BEFs were primarily attributed to a lack of education (Brossard, Shanahan, & Nesbitt, 2007; Cuite, Aquino, & Hallman, 2005) , it is now well recognized that the factors shaping public opinion are complex, multifaceted contextual factors (Butkowski, Pakseresht, Lagerkvist, & Bröring, 2017) , centering around subjective risk perception (Slovic, 1987) . For instance, a recent study revealed that consumer risk perception associated with plant biotechnology differs depending on the application area (food vs. bioenergy) and is lower for applications in bioenergy (Butkowski et al., 2017) . Recent studies have revealed that people tend to interpret information about BEFs in personally relevant ways, depending on their specific level of involvement; therefore, conversations about BEFs must take the form of more than just education (Blancke, Grunewald, & De Jaeger, 2017) .
Indeed, for both scientifically educated people and the general public alike, past experience, values, social norms, and technology application area all contribute to the contextualization of risk perception and decision-making (Bray & Ankeny, 2017; Christoph, Bruhn, & Roosen, 2008; Frewer et al., 2011; Knight, 2006) .
Critically however, additional education is likely to be useful in increasing the sophistication of public knowledge about BEFs so as to enable people to differentiate and evaluate BEFs objectively on function and application, rather than viewing all products in broad categories and/or through the same lens. This in turn helps promote case-by-case decision-making rather than, potentially uninformed, catchall judgments (Christoph et al., 2008; Knight, 2006) , which are problematic since genetic engineering and biotechnology is simply a set of tools that may be used for any purpose, regardless of the objective and/or subjective and transparent communication about their research and technologies (Lewandowsky, Mann, Brown, & Friedman, 2016) , especially focusing on understanding consumer viewpoints so as to debate on common ground (Blancke et al., 2017) .
Innovation Challenge 2: Determining Product-Market Fit in Interconnected and

Convergent FAB Markets
Determining product-market fit-often defined as "being in a good market with a product that can satisfy that market" (Blank, 2005) -, is often one of the most critical aspects of successful innovation, both for aligning required product performance characteristics with customer needs (Nobel, 2011) , as well as for enabling customer creation/growth and the scaling of a venture (Blank, 2005) .
Although a challenge in many sectors, establishing product-market fit can be even more complex in the FAB sector due to the prevalence of innovations that span highly interconnected and convergent markets ( Table 2) . Indeed, many of the innovation opportunities in the FAB sector are driven by industry convergence of existing value chains to either create complementary value chains enabling new industries (e.g. nutraceuticals, functional foods, probiotics), or else substitutive value chains driving alternative, technology augmented industries (e.g. food e-commerce, drones/robotics, bioenergy, 'green' chemistry).
As such, convergence-driven, alternative value chains present FAB ventures with specialized challenges in absorptive capacity-i.e. the ability to acquire and internalize different technological and market-related knowledge required to compete effectively in convergent industries (Cohen & Levinthal, 1990 )-which can be costly for firms, especially early-stage ventures that are resource-limited . The product-market fit challenge is further compounded in the case of platform technologies-those which "will yield benefits for a wide range of sectors of the economy and/or society" (Keenan, 2003 )-spanning convergent industries.
Examples of such technologies in the FAB sector are platform farm management and food supply chain technologies that are broadly applicable; however, differences in crop type, geography, and supply chain structure necessitate differential implementation of the technology in each market (Fuglie & Kascak, 2001) . Similarly, innovative food technologies, such as alternative proteins, biobased ingredients, and recombinant enzyme production all utilize common technology tool sets (i.e. synthetic biology and microbial fermentation) for their development; however, differences in target technology application and, more importantly, market considerations require careful evaluation of each instance of the platform technology. For example, the use of synthetic biology and genetic engineering in medical/pharmaceutical applications has paradoxically been well tolerated by consumers (Marris, 2001 ); yet, the same platform technology is minimally tolerated in agricultural and food applications, thereby necessitating case-by-case analysis of adoption barriers and investment of specific resources to overcome application-specific technological and market uncertainty.
It is clear that the convergence of once-disparate industries driving the emergence of novel value chains Further promoting industrial convergence is the fact that as industries and technologies mature, dominant designs tend to emerge that drive the sector to switch from technical product innovation to process-based innovation (Abernathy & Utterback, 1978) . While this can offer firms a competitive price advantage, it has the consequences of limiting new, potentially more innovative, entrants and technologies into the market and may even lead to commoditization of technology within a sector as price becomes the predominant product differentiator (Abernathy & Utterback, 1978; Maine, Thomas, & Utterback, 2014) . This is also particularly relevant to the FAB sector as the food and agriculture markets tend be to highly mature, slow-to-adopt, and price-sensitive industries in which the pace of innovation has been significantly slower than other industries, i.e. information technology (Boehlje & Bröring, 2009) .
Given the duality of opportunity and challenge that convergent industries pose for M A N U S C R I P T (Maine & Garnsey, 2006) . As the name implies, this approach aims to identify and evaluate technology and market barriers to establishing productmarket fit (as discussed above). This innovation management capability also analyzes the critical interplay of such factors so as to facilitate finding productmarket fit and guide initial commercialization efforts for ventures ( Table 3) .
A C C E P T E D
Product-market fit is a function of technological and market uncertainties involved in innovation development and deployment. Examples of technology uncertainty include the need for complementary or process innovation (e.g. manufacturing innovation to produce technology at scale) and the need for customized design or R&D in order to implement the technology (Maine & Garnsey, 2006) . In the context of the FAB sector, such technological uncertainty is likely to be influenced by inherent biological variability in living systems (i.e. crops/animals and raw materials/ingredients to which technologies are applied), geographical variability, and seasonal / climate influence (Boehlje & Bröring, 2009) . General examples of market uncertainty include regulatory structures, the incumbent landscape and value chain positioning, a lack of trialability or visibility (e.g.
technologies that cannot easily be demonstrated prior to financial commitment), and customer adoption rates (Maine & Garnsey, 2006) . In the context of the FAB sector, such market uncertainty includes regulatory hurdles for approvals of novel foods, food ingredients, and food processing methods, veterinary regulations, environmental regulations, as well as a technologically conservative incumbent and customer landscape (Boehlje & Bröring, 2009) , and economic constraints on value appropriability due to historically slim food and agriculture sector profit margins and/or commodity pricing structures 3 (Boehlje, 2004; Cahoon, 2007 (Rogers, 2004) , markets with specialized incentives to adopt technology (e.g. legislation, subsidy or tax credits), or markets with specialized technology readiness (e.g. reduced need for complementary innovation and/or regulatory barriers) (Maine & Garnsey, 2006) . Moreover, prioritizing markets with near-term potential in this way can not only provide ventures with technical visibility and credibility, but can also provide an important source of early revenue that can be applied to accessing longer-term and/or larger future markets (Maine, Lubik, & Garnsey, 2012) .
A key determinant of product-market fit in convergent sectors (e.g. nutraceuticals and functional foods) is the availability of open innovation opportunities-i.e.
sourcing innovation resources, such as technology, ideas and skills, externally through collaboration and partnerships, rather than developing competencies internally Chesbrough, 2003; Saguy & Sirotinskaya, 2014; Sarkar & Costa, 2008) . Such opportunities mitigate inevitable deficiencies in the crossover of core competencies needed to compete in convergence-driven value chains . In order to bridge such competency gaps quickly and effectively, companies need not only to analyze their existing core competencies, but also to continuously monitor technology and market developments and
dynamic opportunities for open innovation . Using such an approach to evaluate technological capability (i.e. R&D needs vs. current expertise) and market capability (required route to commercialization vs. current commercial channels) provides firms with a system to evaluate strategic options for acquiring required technology and market competencies, and thereby maintaining their dynamic capabilities (Teece, Pisano, & Shuen, 1997) . by forming strategic partnerships that enable a firm to develop the required competencies in an efficient way, i.e. fast-to-develop and low-cost . In the FAB sector, the utility of open innovation practices to bridge competency gaps has been documented ( Saguy & Sirotinskaya, 2014; Sarkar & Costa, 2008) , and is of particular value to the sector since 1) it operates largely within the context of convergent industries; 2) its constituent markets-the food and agribusiness industries-tend to have highly interconnected value chains with a large number of stakeholders servicing a diverse range of interests including intermediate consumers, end-users, regulators, etc. (Sarkar & Costa, 2008) ; 3) it must continually address changing consumer needs and preferences, dynamic regulatory environments, complex retail landscapes, and a highly competitive time-to-market race (Saguy & Sirotinskaya, 2014) . Thus, when establishing product-market fit, alliance opportunities are a critical consideration in the process of technology-market matching.
By critically analyzing the interplay between both positive and negative forces in 
Conclusion
By virtue of its role in innovating global food and agriculture, the FAB-sector faces specialized technology and market adoption uncertainty above and beyond that shared with other SBVs (Figure 1) . In this commentary, we examined relevant innovation management and FAB sector literature to identify and discuss key barriers to successful FAB innovation, including 1) specialized adoption uncertainty stemming from organizational and social factors leading to consumer reticence towards biotechnology-enabled foods, and 2) challenges in obtaining product-market fit as a result of broad technology applicability and the specialized demands of operating in complex and interconnected value chains created through industry convergence and changing consumer preferences.
Through our examination of innovation management literature, we identified key overarching and complementary frameworks for strategic decision making that we believe to be well suited for addressing such barriers to innovation in the FAB sector. Firstly, FAB ventures may benefit from the utility of specialized uncertainty analysis methods, such as TCOS, as a means to identify and resolve barriers to the establishment of cognitive, and especially, sociopolitical legitimacy. Secondly, structured analysis of product-market fit through technology-market matching may help to prioritize beachhead markets and early adopters for whom sociopolitical legitimacy may be more easily established. 
FAB Sector-Specific Challenges
Examples Reference
Specialized adoption uncertainty
High price competition leading to high price sensitivity, especially in B2C food products, (Bunduchi & Smart, 2010; Trott & Simms, 2017) High product failure rates leading to increased costs and reticence towards R&D expenditure, especially in B2C food products (Fuller, 2016; Trott & Simms, 2017) Lack of consumer knowledge and perceived usefulness for biotechnology products Reticence towards genetically modified or bioengineered food and agriculture products, especially in Europe -need for sociopolitical legitimacy M A N U S C R I P T Prioritization of potential markets based on technology and market adoption risk so as to identify product-market fit (Lubik, Garnsey, & Minshall, 2012; Maine & Garnsey, 2006) 2.1 Alliance Partnerships • Complex supply chains • Complex knowledge base • Specialized market economics Forge strong alliance partnerships that provide access to key complementary assets/resources (Das & Teng, 1998; Eisenhardt & Schoonhoven, 1996; Maine & Garnsey, 2006; Maine & Seegopaul, 2016; Maine & Thomas, 2017) 
A C C E P T E D ACCEPTED MANUSCRIPT
Staged Commercialization
• Platform technologies • Specialized market economics • Specialized adoption Sequential entrance into markets so as to maximize resource utility and mitigate risk and uncertainty in achieving high-impact (Kalish, Mahajan, & Muller, 1996; Sinfield & Solis, 2016) M A N U S C R I P T (Adner, 2006; Gans & Stern, 2003; Lubik & Garnsey, 2015; Teece, 1986; 3 Convergence-driven Value Chain Management
A C C E P T E D
• Industry flux • Industry convergence • Complex knowledge base
Utilizing specialized strategies to inform management decision making and close competency gaps in convergent industries 3.1 Open Innovation • Industry flux • Industry convergence • Platform technologies Extensive collaboration and broad networks of expertise with academia, key opinion leaders, and consultants so as to minimize costly knowledge gaps and subsequent internal expertise build out during technology development (Chesbrough, 2006; Maine et al., 2014; Pellegrini et al., 2014; Sarkar & Costa, 2008) 3.2 Convergence and Value Chain Analysis
• Industry flux • Industry convergence • Complex supply chains
Critical evaluation of drivers for convergence so as to predict and proactively respond to industry convergence 
DUI Innovation • Conservative markets • Competing innovation goals • Specialized market economics
Learning-by-doing, by-using, and by interacting (DUI)' to facilitate innovation in low and medium technology industries (Fitjar & Rodríguez-Pose, 2013; Jensen et al., 2007; Trott & Simms, 2017) 3.4 Specialized Knowledge Management
• Complex supply chains • Complex knowledge base • Specialized adoption uncertainty Collaboration and cooperation across the value chain to transfer technical and market knowledge so as to close competency gaps-'in-context' analysis (T. Brown, 2005; Golembiewski et al., 2015; Nussbaum, 2004) 
